Map Pharmaceuticals, Telesso Technologies Ltd. deal

Map acquired all assets related to Telesso’s supercritical fluid ( SCF) drug delivery technology for an undisclosed sum. Telesso also is eligible for late stage clinical and regulatory milestones for ...